CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to TLSA

Phase 2

Development Phase

1

Upcoming Catalysts

3

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Apr '27
TLSAPhase 2

Foralumab Nasal Phase 2 Est. Readout

Foralumab Nasal
Apr 2027~
CT.gov
00%
Development History
Nov '26
TLSAPhase 2
✓Positive

Foralumab Nasal Phase 2 Est. Readout

Foralumab Nasal
Nov 2026~
CT.gov
Nov '26
TLSAPhase 2
✓Positive

Foralumab Nasal Phase 2 Est. Readout

Foralumab Nasal
Nov 2026~
CT.gov
Nov '26
TLSAPhase 2
✓Positive

Foralumab Nasal Phase 2 Est. Readout

Foralumab Nasal
Nov 2026~
CT.gov
Competitive Landscape

2 competitors in Multiple System Atrophy

View Full Landscape
Drug Information

Target Indication

Multiple System Atrophy

Clinical Trial

NCT06868628

Last updated: 12/19/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.